Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
FAP Identified Subjects	STARTED	Matched Control	13
FAP Identified Subjects	STARTED	All Celecoxib Treated	55
FAP Identified Subjects	COMPLETED	Matched Control	13
FAP Identified Subjects	COMPLETED	All Celecoxib Treated	54
FAP Identified Subjects	NOT COMPLETED	Matched Control	0
FAP Identified Subjects	NOT COMPLETED	All Celecoxib Treated	1
FAP Analyzed Subjects	STARTED	Matched Control	13
FAP Analyzed Subjects	STARTED	All Celecoxib Treated	54
FAP Analyzed Subjects	COMPLETED	Matched Control	13
FAP Analyzed Subjects	COMPLETED	All Celecoxib Treated	51
FAP Analyzed Subjects	NOT COMPLETED	Matched Control	0
FAP Analyzed Subjects	NOT COMPLETED	All Celecoxib Treated	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00151476/flow